|
OTC Healthcare in the Netherlands to 2011
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
|||||||||||
| Zahlen und Fakten zur Studie: |
*Discover the major quantitative trends affecting the OTC Healthcare markets *Understand consumers' consumption and expenditure patterns *Understand the future direction of the market with reliable historical data and full five year forecasting 189 pages | |||||||||||
| Inhalt der Studie: |
This databook is a detailed information resource covering all the key data points on OTC Healthcare in the Netherlands. It includes comprehensive value volume segmentation and market share data. The d.....
This databook is a detailed information resource covering all the key data points on OTC Healthcare in the Netherlands. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011. Report Highlights The market for OTC Healthcare in the Netherlands increased between 2001-2006, growing at an average annual rate of 3.4%. The leading company in the market in 2006 was Pfizer Inc. The second-largest player was Bayer AG with Bional in third place. [Studien Infos ausblenden] |
|||||||||||
|
Chapter 1 EXECUTIVE SUMMARY 2 Summary Market Level - OTC Healthcare 2 Summary category level - Analgesics 3 Summary category level - Cough and Cold Preparations 4 Summary category level - Traditional Medicines 5 Summary category level - First Aid Kits 6 Summary category level - Indigestion Preparations 7 Summary category level - Vitamins and Minerals 8 Summary category level - Plasters & Bandages 9 Summary category level - Medicated Skin Products 10 Summary category level - Other OTC Healthcare Products 11 Summary category level - Topical OTC Medicines 12 Chapter 2 INTRODUCTION 13 What is this report about? 13 How to use this report 13 Market Definition 14 Chapter 3 MARKET OVERVIEW 31 Value Analysis, 2001-2006 31 Value Analysis, 2006-2011 33 Value Analysis, US$ 2001-2006 36 Value Analysis, US$ 2006-2011 37 Company and Brand Share Analysis 39 Expenditure & consumption per capita 46 Chapter 4 LEADING COMPANY PROFILES 50 Pfizer Inc 50 Bayer AG 52 Chapter 5 CATEGORY ANALYSIS - ANALGESICS 54 Value Analysis, 2001-2006 54 Value Analysis, 2006-2011 55 Value Analysis, US$ 2001-2006 57 Value Analysis, US$ 2006-2011 58 Company and Brand Share Analysis 59 Expenditure & consumption per capita 62 Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS 64 Value Analysis, 2001-2006 64 Value Analysis, 2006-2011 65 Value Analysis, US$ 2001-2006 67 Value Analysis, US$ 2006-2011 68 Company and Brand Share Analysis 70 Expenditure & consumption per capita 73 Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES 76 Value Analysis, 2001-2006 76 Value Analysis, 2006-2011 77 Value Analysis, US$ 2001-2006 78 Value Analysis, US$ 2006-2011 78 Company and Brand Share Analysis 79 Expenditure & consumption per capita 82 Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS 84 Value Analysis, 2001-2006 84 Value Analysis, 2006-2011 85 Value Analysis, US$ 2001-2006 87 Value Analysis, US$ 2006-2011 87 Company and Brand Share Analysis 88 Expenditure & consumption per capita 91 Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS 93 Value Analysis, 2001-2006 93 Value Analysis, 2006-2011 94 Value Analysis, US$ 2001-2006 96 Value Analysis, US$ 2006-2011 96 Company and Brand Share Analysis 98 Expenditure & consumption per capita 101 Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS 103 Value Analysis, 2001-2006 103 Value Analysis, 2006-2011 104 Value Analysis, US$ 2001-2006 106 Value Analysis, US$ 2006-2011 106 Company and Brand Share Analysis 108 Expenditure & consumption per capita 111 Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES 113 Value Analysis, 2001-2006 113 Value Analysis, 2006-2011 114 Value Analysis, US$ 2001-2006 116 Value Analysis, US$ 2006-2011 117 Company and Brand Share Analysis 119 Expenditure & consumption per capita 122 Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS 125 Value Analysis, 2001-2006 125 Value Analysis, 2006-2011 126 Value Analysis, US$ 2001-2006 128 Value Analysis, US$ 2006-2011 129 Company and Brand Share Analysis 131 Expenditure & consumption per capita 134 Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS 138 Value Analysis, 2001-2006 138 Value Analysis, 2006-2011 139 Value Analysis, US$ 2001-2006 141 Value Analysis, US$ 2006-2011 142 Company and Brand Share Analysis 144 Expenditure & consumption per capita 147 Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES 151 Value Analysis, 2001-2006 151 Value Analysis, 2006-2011 152 Value Analysis, US$ 2001-2006 154 Value Analysis, US$ 2006-2011 155 Company and Brand Share Analysis 157 Expenditure & consumption per capita 159 Chapter 15 COUNTRY COMPARISON 163 Value 163 Market Share 168 Chapter 16 NEW PRODUCT DEVELOPMENT 169 Product launches over time 169 Recent product launches 172 Chapter 17 NETHERLANDS SOCIOECONOMIC PROFILE 173 Country Overview 173 Key Facts 174 Political Overview 175 Netherlands Economic Overview 176 Chapter 18 NETHERLANDS MACROECONOMIC PROFILE 177 Macroeconomic Indicators 177 Chapter 19 RESEARCH METHODOLOGY 184 Methodology overview 184 Secondary research 185 Market modelling 186 Primary research 187 Data finalisation 187 Ongoing research 188 Chapter 20 APPENDIX 189 Future readings 189 How to contact experts in your industry 189 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
Table 1: OTC Healthcare category definitions 15 Table 2: Netherlands OTC Healthcare value, 2001-2006 (EUR m, nominal prices) 32 Table 3: Netherlands OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices) 34 Table 4: Netherlands OTC Healthcare value, 2001-2006 (US$ m nominal prices) 36 Table 5: Netherlands OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices) 37 Table 6: Netherlands OTC Healthcare brand share, by value, 2005-2006 (%) 39 Table 7: Netherlands OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices) 41 Table 8: Netherlands OTC Healthcare company share by value, 2005-2006 (%) 44 Table 9: Netherlands OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices) 45 Table 10: Netherlands OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices) 46 Table 11: Netherlands OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 47 Table 12: Netherlands OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices) 48 Table 13: Netherlands OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices) 49 Table 14: Pfizer Inc Key Facts 50 Table 15: Bayer AG Key Facts 52 Table 16: Netherlands Analgesics value, 2001-2006 (EUR m, nominal prices) 54 Table 17: Netherlands Analgesics value forecast, 2006-2011 (EUR m, nominal prices) 55 Table 18: Netherlands Analgesics value, 2001-2006 (US$ m nominal prices) 57 Table 19: Netherlands Analgesics value forecast, 2006-2011 (US$ m nominal prices) 58 Table 20: Netherlands Analgesics brand share, by value, 2005-2006 (%) 59 Table 21: Netherlands Analgesics value, by brand 2005-2006 (EUR m nominal prices) 59 Table 22: Netherlands Analgesics company share by value, 2005-2006 (%) 61 Table 23: Netherlands Analgesics value, by company, 2005-2006 (EUR m nominal prices) 61 Table 24: Netherlands Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices) 62 Table 25: Netherlands Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 62 Table 26: Netherlands Analgesics expenditure per capita, 2001-2006 (US$ nominal prices) 63 Table 27: Netherlands Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices) 63 Table 28: Netherlands Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices) 64 Table 29: Netherlands Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices) 65 Table 30: Netherlands Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices) 67 Table 31: Netherlands Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices) 68 Table 32: Netherlands Cough and Cold Preparations brand share, by value, 2005-2006 (%) 70 Table 33: Netherlands Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices) 70 Table 34: Netherlands Cough and Cold Preparations company share by value, 2005-2006 (%) 72 Table 35: Netherlands Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices) 72 Table 36: Netherlands Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices) 73 Table 37: Netherlands Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 74 Table 38: Netherlands Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices) 74 Table 39: Netherlands Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices) 75 Table 40: Netherlands Traditional Medicines value, 2001-2006 (EUR m, nominal prices) 76 Table 41: Netherlands Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices) 77 Table 42: Netherlands Traditional Medicines value, 2001-2006 (US$ m nominal prices) 78 Table 43: Netherlands Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices) 78 Table 44: Netherlands Traditional Medicines brand share, by value, 2005-2006 (%) 79 Table 45: Netherlands Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices) 79 Table 46: Netherlands Traditional Medicines company share by value, 2005-2006 (%) 81 Table 47: Netherlands Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices) 81 Table 48: Netherlands Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices) 82 Table 49: Netherlands Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 82 Table 50: Netherlands Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices) 83 Table 51: Netherlands Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices) 83 Table 52: Netherlands First Aid Kits value, 2001-2006 (EUR m, nominal prices) 84 Table 53: Netherlands First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices) 85 Table 54: Netherlands First Aid Kits value, 2001-2006 (US$ m nominal prices) 87 Table 55: Netherlands First Aid Kits value forecast, 2006-2011 (US$ m nominal prices) 87 Table 56: Netherlands First Aid Kits brand share, by value, 2005-2006 (%) 88 Table 57: Netherlands First Aid Kits value, by brand 2005-2006 (EUR m nominal prices) 88 Table 58: Netherlands First Aid Kits company share by value, 2005-2006 (%) 90 Table 59: Netherlands First Aid Kits value, by company, 2005-2006 (EUR m nominal prices) 90 Table 60: Netherlands First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices) 91 Table 61: Netherlands First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 91 Table 62: Netherlands First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices) 92 Table 63: Netherlands First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices) 92 Table 64: Netherlands Indigestion Preparations value, 2001-2006 (EUR m, nominal prices) 93 Table 65: Netherlands Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices) 94 Table 66: Netherlands Indigestion Preparations value, 2001-2006 (US$ m nominal prices) 96 Table 67: Netherlands Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices) 96 Table 68: Netherlands Indigestion Preparations brand share, by value, 2005-2006 (%) 98 Table 69: Netherlands Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices) 98 Table 70: Netherlands Indigestion Preparations company share by value, 2005-2006 (%) 100 Table 71: Netherlands Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices) 100 Table 72: Netherlands Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices) 101 Table 73: Netherlands Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 101 Table 74: Netherlands Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices) 102 Table 75: Netherlands Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices) 102 Table 76: Netherlands Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices) 103 Table 77: Netherlands Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices) 104 Table 78: Netherlands Vitamins and Minerals value, 2001-2006 (US$ m nominal prices) 106 Table 79: Netherlands Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices) 106 Table 80: Netherlands Vitamins and Minerals brand share, by value, 2005-2006 (%) 108 Table 81: Netherlands Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices) 108 Table 82: Netherlands Vitamins and Minerals company share by value, 2005-2006 (%) 110 Table 83: Netherlands Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices) 110 Table 84: Netherlands Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices) 111 Table 85: Netherlands Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 111 Table 86: Netherlands Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices) 112 Table 87: Netherlands Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices) 112 Table 88: Netherlands Plasters & Bandages value, 2001-2006 (EUR m, nominal prices) 113 Table 89: Netherlands Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices) 114 Table 90: Netherlands Plasters & Bandages value, 2001-2006 (US$ m nominal prices) 116 Table 91: Netherlands Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices) 117 Table 92: Netherlands Plasters & Bandages brand share, by value, 2005-2006 (%) 119 Table 93: Netherlands Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices) 119 Table 94: Netherlands Plasters & Bandages company share by value, 2005-2006 (%) 121 Table 95: Netherlands Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices) 121 Table 96: Netherlands Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices) 122 Table 97: Netherlands Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 123 Table 98: Netherlands Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices) 123 Table 99: Netherlands Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices) 124 Table 100: Netherlands Medicated Skin Products value, 2001-2006 (EUR m, nominal prices) 125 Table 101: Netherlands Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices) 126 Table 102: Netherlands Medicated Skin Products value, 2001-2006 (US$ m nominal prices) 128 Table 103: Netherlands Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices) 129 Table 104: Netherlands Medicated Skin Products brand share, by value, 2005-2006 (%) 131 Table 105: Netherlands Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices) 131 Table 106: Netherlands Medicated Skin Products company share by value, 2005-2006 (%) 133 Table 107: Netherlands Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices) 133 Table 108: Netherlands Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices) 134 Table 109: Netherlands Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 135 Table 110: Netherlands Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices) 136 Table 111: Netherlands Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices) 137 Table 112: Netherlands Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices) 138 Table 113: Netherlands Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices) 139 Table 114: Netherlands Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices) 141 Table 115: Netherlands Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices) 142 Table 116: Netherlands Other OTC Healthcare Products brand share, by value, 2005-2006 (%) 144 Table 117: Netherlands Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices) 144 Table 118: Netherlands Other OTC Healthcare Products company share by value, 2005-2006 (%) 146 Table 119: Netherlands Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices) 146 Table 120: Netherlands Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices) 147 Table 121: Netherlands Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 148 Table 122: Netherlands Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices) 149 Table 123: Netherlands Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices) 150 Table 124: Netherlands Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices) 151 Table 125: Netherlands Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices) 152 Table 126: Netherlands Topical OTC Medicines value, 2001-2006 (US$ m nominal prices) 154 Table 127: Netherlands Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices) 155 Table 128: Netherlands Topical OTC Medicines brand share, by value, 2005-2006 (%) 157 Table 129: Netherlands Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices) 157 Table 130: Netherlands Topical OTC Medicines company share by value, 2005-2006 (%) 158 Table 131: Netherlands Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices) 158 Table 132: Netherlands Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices) 159 Table 133: Netherlands Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 160 Table 134: Netherlands Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices) 161 Table 135: Netherlands Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices) 162 Table 136: Global OTC Healthcare market value, 2006 163 Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) – Top 5 countries 166 Table 138: Leading players - Top 5 countries 168 Table 139: Netherlands OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006 169 Table 140: Netherlands OTC Healthcare new product launches (reports), by flavor and fragrances 2006 170 Table 141: Netherlands OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006 170 Table 142: Netherlands OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006 171 Table 143: Netherlands OTC Healthcare new product launches (reports) - Recent 5 launches 172 Table 144: Netherlands Key Facts 174 Table 145: Netherlands population, by age group, 2000-2005 (millions) 177 Table 146: Netherlands population forecast, by age group, 2005-2010 (millions) 178 Table 147: Netherlands population, by gender, 2000-2005 (millions) 178 Table 148: Netherlands population forecast, by gender, 2005-2010 (millions) 179 Table 149: Netherlands real GDP, 2000-2005 (EUR bn, 2005 prices) 179 Table 150: Netherlands real GDP forecast, 2005-2010 (EUR bn, 2005 prices) 180 Table 151: Netherlands nominal GDP, 2000-2005 (EUR bn, nominal prices) 180 Table 152: Netherlands real GDP, 2000-2005 (US$ bn, 2005 prices) 181 Table 153: Netherlands real GDP forecast, 2005-2010 (US$ bn, 2005 prices 181 Table 154: Netherlands consumer price index, 2000-2005 (2000=100) 182 Table 155: Netherlands consumer price index, 2005-2010 (2000=100) 182 Table 156: Netherlands exchange rate, 2000-2005 183 Figure 1: Netherlands OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices) 35 Figure 2: Netherlands OTC Healthcare category growth comparison, by value, 2001-2011 38 Figure 3: Netherlands OTC Healthcare company share, by value, 2005-2006 (%) 43 Figure 4: Netherlands Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices) 56 Figure 5: Netherlands Analgesics category growth comparison, by value, 2001-2011 58 Figure 6: Netherlands Analgesics company share, by value, 2005-2006 (%) 60 Figure 7: Netherlands Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices) 66 Figure 8: Netherlands Cough and Cold Preparations category growth comparison, by value, 2001-2011 69 Figure 9: Netherlands Cough and Cold Preparations company share, by value, 2005-2006 (%) 71 Figure 10: Netherlands Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices) 77 Figure 11: Netherlands Traditional Medicines company share, by value, 2005-2006 (%) 80 Figure 12: Netherlands First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices) 86 Figure 13: Netherlands First Aid Kits company share, by value, 2005-2006 (%) 89 Figure 14: Netherlands Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices) 95 Figure 15: Netherlands Indigestion Preparations category growth comparison, by value, 2001-2011 97 Figure 16: Netherlands Indigestion Preparations company share, by value, 2005-2006 (%) 99 Figure 17: Netherlands Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices) 105 Figure 18: Netherlands Vitamins and Minerals category growth comparison, by value, 2001-2011 107 Figure 19: Netherlands Vitamins and Minerals company share, by value, 2005-2006 (%) 109 Figure 20: Netherlands Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices) 115 Figure 21: Netherlands Plasters & Bandages category growth comparison, by value, 2001-2011 118 Figure 22: Netherlands Plasters & Bandages company share, by value, 2005-2006 (%) 120 Figure 23: Netherlands Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices) 127 Figure 24: Netherlands Medicated Skin Products category growth comparison, by value, 2001-2011 130 Figure 25: Netherlands Medicated Skin Products company share, by value, 2005-2006 (%) 132 Figure 26: Netherlands Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices) 140 Figure 27: Netherlands Other OTC Healthcare Products category growth comparison, by value, 2001-2011 143 Figure 28: Netherlands Other OTC Healthcare Products company share, by value, 2005-2006 (%) 145 Figure 29: Netherlands Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices) 153 Figure 30: Netherlands Topical OTC Medicines category growth comparison, by value, 2001-2011 156 Figure 31: Global OTC Healthcare market split (value terms, 2006) – Top 5 countries 164 Figure 32: Global OTC Healthcare market value, 2001 – 2006 (Top 5 countries) 167 Figure 33: Map of Netherlands 174 Figure 34: Annual data review process 185 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
